Avanos Medical (AVNS) Liabilities from Discontinued Operations (2016 - 2024)
Historic Liabilities from Discontinued Operations for Avanos Medical (AVNS) over the last 6 years, with Q3 2024 value amounting to $52.9 million.
- Avanos Medical's Liabilities from Discontinued Operations rose 201600.0% to $52.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $52.9 million, marking a year-over-year increase of 201600.0%. This contributed to the annual value of $63.7 million for FY2023, which is 79718.31% up from last year.
- According to the latest figures from Q3 2024, Avanos Medical's Liabilities from Discontinued Operations is $52.9 million, which was up 201600.0% from $52.7 million recorded in Q2 2024.
- Avanos Medical's Liabilities from Discontinued Operations' 5-year high stood at $63.7 million during Q4 2023, with a 5-year trough of $2.5 million in Q3 2023.
- Moreover, its 3-year median value for Liabilities from Discontinued Operations was $52.2 million (2024), whereas its average is $33.4 million.
- Its Liabilities from Discontinued Operations has fluctuated over the past 5 years, first surged by 79718.31% in 2023, then surged by 201600.0% in 2024.
- Quarter analysis of 3 years shows Avanos Medical's Liabilities from Discontinued Operations stood at $7.1 million in 2022, then skyrocketed by 797.18% to $63.7 million in 2023, then fell by 16.95% to $52.9 million in 2024.
- Its last three reported values are $52.9 million in Q3 2024, $52.7 million for Q2 2024, and $52.2 million during Q1 2024.